EUVIMEDEUVIMED entdecken
Open Access

Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study

Lynda E Polgreen iD, Eva Villa-Lopez, Liz Chen, Ziyue Liu, Amy Katz, Corinne Parks-Schenck, Marian Hart, Erik A Imel, Michael J Econs

The Journal of Clinical Endocrinology & Metabolism · 18.02.2025 · 110 (3) · e607-e614

DOI: 10.1210/clinem/dgae285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.04.2024. Verfasst von Lynda E Polgreen und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. Hauptthemen laut MEDLINE: Osteopetrosis, Patient Reported Outcome Measures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Autosomal dominant osteopetrosis (ADO) is a rare sclerotic bone disease characterized by impaired osteoclast activity, resulting in high bone mineral density and skeletal fragility. The full phenotype and disease burden on patients’ daily lives has not been systematically measured.

Objective

We developed an online registry to ascertain population-based data on the spectrum and rate of progression of disease and to identify relevant patient-centered outcomes that could be used to measure treatment effects and guide the design of future clinical trials.

Methods

Cross-sectional data from participants with osteopetrosis were collected using an online REDCap-based database. Thirty-four participants with a confirmed diagnosis of ADO, aged 4-84 years were included. Participants aged 18 years and older completed the PROMIS 57, participants aged 8-17 years completed the PROMIS Pediatric 49, and parents of participants aged <18 years completed the PROMIS Parent Proxy 49.

Results

Based on the PROMIS 57, relative to the general population, adults with ADO reported low physical function and low ability to participate in social roles and activities, and high levels of anxiety, fatigue, sleep problems, and pain interference. Daily pain medications were reported by 24% of the adult population. In contrast, neither pediatric participants nor their parent proxy reported a negative impact on health-related quality of life.

Conclusion

Data from this registry demonstrate the broad spectrum of ADO disease severity and high impact on health-related quality of life in adults with ADO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopetrosisPatient Reported Outcome MeasuresHumansMaleAdolescentFemaleChildRegistriesMiddle AgedAdultCross-Sectional StudiesAgedChild, PreschoolYoung AdultAged, 80 and overQuality of LifeDisease Progression

Stichwörter der Autor:innen

autosomal dominant osteopetrosisosteopetrosispatient-reported outcomesregistry

Autor:innen und Institutionen

  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
  • Department of Biostatistics and Data Science, Indiana University School of Medicine, Indianapolis, IA 46202, USA.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IA 46202, USA.
  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IA 46202, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IA 46202, USA.

ORCID-Profile: Lynda E Polgreen

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Center for Advancing Translational Sciences
  • Indiana School of Medicine

Zitieren

APA

Polgreen, L. E., Villa-Lopez, E., Chen, L., Liu, Z., Katz, A., Parks-Schenck, C., Hart, M., Imel, E. A., & Econs, M. J. (2025). Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study. The Journal of Clinical Endocrinology & Metabolism, 110(3), e607-e614. https://doi.org/10.1210/clinem/dgae285

Vancouver

Polgreen LE, Villa-Lopez E, Chen L, Liu Z, Katz A, Parks-Schenck C, et al. Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(3):e607-e614. doi:10.1210/clinem/dgae285

BibTeX
@article{Polgreen2025,
  author = {Polgreen, Lynda E and Villa-Lopez, Eva and Chen, Liz and Liu, Ziyue and Katz, Amy and Parks-Schenck, Corinne and Hart, Marian and Imel, Erik A and Econs, Michael J},
  title = {Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {3},
  pages = {e607--e614},
  doi = {10.1210/clinem/dgae285}
}
Kostenlos starten →